Qube Research & Technologies (QRT)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-56,200	Closed	-$5.06M	–	3933
2024 Q4	$5.06M	Hold	56,200	–	–	0.01%	1494
2024 Q3	$5.55M	Buy	56,200 +1,600	+3%	+$157K	0.01%	1336
2024 Q2	$5.06M	Sell	54,600 -38,400	-41%	-$3.44M	0.01%	1244
2024 Q1	$8.82M	Buy	+93,000	New	+$8.63M	0.01%	917
2023 Q4	–	Sell	-33,400	Closed	-$2.44M	–	4802
2023 Q3	$2.44M	Buy	+33,400	New	+$2.67M	0.01%	1275

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Qube Research & Technologies (QRT)'s XBI Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 90% in Q2 2026, selling an estimated $23.2M and leaving 19,211 shares worth $3.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1900.

Qube Research & Technologies (QRT) first reported a position in XBI in Q1 2020 and has held it in 18 quarters since. The position peaked at $28.6M in Q4 2020. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Qube Research & Technologies (QRT) held 19,211 shares of State Street SPDR S&P Biotech ETF worth $3.04M as of Q2 2026.
Qube Research & Technologies (QRT) sold 171,506 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $23.2M.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1900 holding.
Qube Research & Technologies (QRT) first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 18 quarters since.
Qube Research & Technologies (QRT)'s State Street SPDR S&P Biotech ETF position peaked at $28.6M in Q4 2020.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.